2025 was a year of pace and progress and OncoDaily was in the middle of it every day. We covered the science, followed the people behind the work, and helped the community stay connected to what matters, when it matters.
Here’s What We Built Together
Content That Kept Moving With Oncology
This year, OncoDaily passed a major milestone: 30,000+ published articles, including 1,500+ original editorial articles. Behind those numbers is daily work turning new data, clinical updates, and global oncology developments into content the community can actually use.
A major part of our scientific coverage stayed close to practice: throughout 2025, we reported on a large number of FDA approvals and label expansions, adding context around the decision, the indication, and what it may change for patients and clinical teams.
Introducing OncoDaily LA: A New Hub for Cancer Media in California
Los Angeles, CA — OncoDaily announced the launch of OncoDaily LA, a new regional hub focused on advancing oncology storytelling and cancer advocacy across Southern California. Led by Martin Harutyunyan, Director of OncoDaily LA, the initiative integrates clinical expertise with cultural and community-driven narratives, amplifying the voices of clinicians, patients, caregivers, and advocates. As part of the global OncoDaily platform, OncoDaily LA introduces a localized, multidisciplinary approach to cancer media, spanning youth outreach, supportive and palliative care perspectives, and innovative digital formats, including the newly launched OncoDaily LA TV on YouTube.
The New Big Three in OncoDaily
In 2025, we sharpened our coverage by building three focused platforms that became a real engine inside OncoDaily: GI, IO, and Biotech. Clearer structure, deeper context, and the right updates reaching the right audience fast.
OncoDaily GI became our dedicated space for gastrointestinal oncology covering colorectal, gastric, pancreatic, hepatobiliary, and esophageal cancers with steady attention to practice-changing trial results, guideline-moving evidence, and late-breaking congress highlights. Alongside the weekly 10 posts not to miss, we also published scientific articles in GI, turning important data into clear, usable context for clinicians and the wider oncology community.
OncoDaily IO grew into a focused home for immune-oncology, tracking checkpoint strategies, combinations, resistance, biomarkers, endpoints, toxicity management, and the real-world questions that follow approvals and major readouts. Each week, the IO “top 10” helped readers stay aligned with what was actually moving the field, supported by IO-focused scientific articles that went deeper than the headline.
OncoDaily Biotech followed the innovation engine behind cancer care, pipelines, platforms, early clinical signals, translational science, and the steps that happen long before therapies reach guidelines.
The Series That Became a Landmark
“The 100 Most Influential People in Oncology in 2025”, we recognized 100 people who helped build modern oncology and continue to push it forward. The series travelled widely across social media and created strong engagement because the oncology community cares about leadership, vision, and real impact.
OncoDaily Medical Journal: A Bigger Scientific Community
In 2025, the OncoDaily Medical Journal grew into a stronger, more connected scientific home. We welcomed 200+ new Editorial Board members, bringing our total to 335, a clear sign of trust, momentum, and shared responsibility for high-quality oncology publishing.
At the same time, OncoDaily Medical Journal (ODMJ) had a strong year of output and partnerships. In 2025, ODMJ published articles and partnered with major meetings including SIOP Asia 2025, St. Jude Global Alliance, Euro Regional Meeting 2025, the Pediatric Oncology East & Mediterranean (POEM) Group 4th Annual Meeting, the 7th Emirates Pediatric Hematology & Oncology Conference, and the 6th Hybrid Annual Pakistan Pediatric Neuro-Oncology Symposium.
ODMJ also published approximately 500 conference abstracts and reached an important milestone by becoming indexed in Google Scholar a step that strengthens visibility, discoverability, and long-term scientific reach.
What OncoDaily Hosted in 2025: Global Oncology Events and Flagship Initiatives
In 2025, OncoDaily moved beyond coverage to actively host and convene global oncology initiatives, creating spaces for scientific exchange, policy dialogue, and collective action across cancer care.
Global OncoThon: Uniting Medicine, Advocacy, and Public Voices for Childhood Cancer
One of the most visible initiatives was the Second Global OncoThon, a 24-hour virtual event co-led by OncoDaily and the International Society of Pediatric Oncology (SIOP), held on Childhood Cancer Awareness Day. The event brought together clinicians, researchers, patient advocates, parents, and global public figures in support of childhood cancer research. Participants included Lionel Messi, Richard Gere and Alejandra Gere, Paco Arango, and Princess Dina Mired, Patron of SIOP and mother of a cancer survivor. The program highlighted the global inequities in pediatric cancer outcomes and underscored the urgent need for sustained research funding, early diagnosis, and access to essential medicines worldwide.
Global Voices in Renal Oncology (VIRO)
OncoDaily also hosted Global Voices in Renal Oncology (VIRO), a dedicated international summit focused on kidney cancer. Co-chaired by Rana McKay and Yüksel Ürün, the event featured more than 50 expert speakers from across continents. VIRO provided a multidisciplinary platform to discuss evolving standards of care, emerging data, and real-world challenges in renal oncology, reinforcing OncoDaily’s role in facilitating high-level, disease-focused scientific dialogue.
Highlights from Day 2 of VIRO 2025: Charting the Future of Renal Oncology on the Final Day
OncoDaily Grand Rounds at ESMO 2025: GI Edition
During the ESMO Congress in Berlin, OncoDaily hosted OncoDaily Grand Rounds: GI Edition with Dr. Yelena Janjigian and Friends, a live, in-person educational program dedicated to gastrointestinal oncology. Chaired by Yelena Janjigian of Memorial Sloan Kettering Cancer Center, the session brought together Filippo Pietrantonio, Samuel J. Klempner, and Elena Elimova. The discussion focused on translating late-breaking ESMO data into practical clinical decision-making, emphasizing applicability, nuance, and real-world impact rather than headline results alone.
Essential Medicines for Children with Cancer: From Access to Action
In a separate global virtual forum, OncoDaily hosted “Essential Medicines for Children with Cancer: From Access to Action,” addressing one of the most pressing issues in pediatric oncology: access to life-saving drugs. The forum convened senior leaders and experts from the World Health Organization, St. Jude Global, and SIOP, alongside pediatric oncologists from high-, middle-, and low-income settings. Discussions centered on the WHO Essential Medicines List for Children, barriers to access, and coordinated global strategies to improve survival outcomes for children with cancer worldwide.
And we made room for celebration too: in 2025, we hosted two OncoDaily Parties, including Chicago Party & Berlin Party, because community is built not only through work, but through connection.
20 Posts Not to Miss from ASCO 2025
On May 30th, the OncoDaily Party 2025 was also held, featuring the presentation of the Yvonne Awards, which recognized outstanding contributions in categories such as Breakthrough Research, Global Oncology, Community Oncology, Leadership, Mentorship, Challenging the Status Quo, Pediatric Oncology, and the Humanitarian Award.
Yvonne Award 2025: Recognizing Emerging Leaders in Oncology at ASCO
In 2025, OncoDaily presented the Yvonne Awards during the ASCO Annual Meeting in Chicago, formally honoring young innovators and leaders advancing cancer care. Symbolized by a Y-shaped sculpture inspired by the strength and longevity of the yew tree, the award recognizes excellence across breakthrough research, global oncology, leadership, mentorship, pediatric oncology, humanitarian impact, and community oncology. The Yvonne Award ceremony took place as part of the OncoDaily Party on May 30, with awardees selected by an international nomination committee composed of senior global oncology leaders.
OncoDaily Party Berlin 2025: Community and Connection During ESMO
Separate from the Yvonne Award, OncoDaily hosted the OncoDaily Party Berlin 2025 during the ESMO Congress, creating one of the most vibrant community gatherings of ESMO week. Co-chaired by Yelena Janjigian and Giuseppe Curigliano, the event brought together more than 500 clinicians, researchers, and innovators from over 10 countries and five continents. With no formal program and no slides, the Berlin party focused on networking, collaboration, and human connection—reinforcing OncoDaily’s role as a platform that brings the global oncology community together beyond the lecture hall.
Throughout the year, our congress and event visuals became part of how people recognized our coverage especially around major moments such as ESMO Congress 2025 , ASCO 2025.
OncoDaily Magazine: Special Issues
In 2025, we also brought OncoDaily to the world’s biggest stages with special OncoDaily Magazine issues for ASCO and ESMO.
At ASCO 2025 in Chicago, we launched the second issue of OncoDaily Magazine and distributed thousands of copies onsite. Built as a two-sided edition (Part 1 & Part 2), it captured the spirit of the meeting breakthrough science, leadership, and the stories that keep oncology human.
A New Look: Website, Logo and Visual Identity
We introduced a refreshed website design, built for smoother reading, clearer navigation, and easier discovery of both news and scientific content.
We also updated the OncoDaily logo, creating a cleaner, stronger identity across platforms.
Social Media: Daily Presence, Real Growth
In 2025, we published more than 30,000 oncology news updates across our social platforms, maintaining a consistent daily presence that kept oncology visible year-round. According to Ahrefs data, the OncoDaily website became TOP 1 The most visited oncology news website globally, while our content generated over 1 million impressions per month, reflecting sustained international reach and engagement.
Our LinkedIn audience grew by 100% compared with the previous year, positioning OncoDaily as a leading oncology news platform, with monthly impressions ranking between CNN and BBC in overall visibility. Behind the numbers was what mattered most—reach, engagement, shares, and conversations that helped evidence-based oncology information travel further across the global cancer community.
YouTube became another major pillar of our daily work in 2025
At the same time, OncoDaily TV continued to scale its video platform, reaching 78K subscribers and delivering 760+ published videos, further amplifying expert voices, educational content, and global oncology conference coverage.
From interviews and event moments to expert insights and key oncology updates, the channel grew into a fast, accessible way to follow the field especially for people who prefer to watch, listen, and share on the go.
OncoDaily Newsletter: 2 Million Sends, One Purpose
In 2025, OncoDaily’s newsletter became a major part of how the community stayed in sync with the field. Across the year, we managed email campaigns with a total send volume of 2,000,000 emails delivering updates directly to inboxes, at the pace oncology demands.
Cancer World: Back in Print
January marked a special return: Cancer World came back as a printed publication. In 2025, we released 12 print issues, bringing long-form oncology storytelling back to the page.
This year also opened a new leadership chapter with Lidia Schapira joining as Co–Editor-in-Chief, strengthening the editorial direction and widening what Cancer World can do.
Across the year, Cancer World featured interviews with leaders shaping health policy and cancer advocacy, including MEP Tilly Metz, MEP Nikos Papandreou, Latvian Minister of Health Hosams Abu Meri, Irish Minister of State at the Department of Finance Robert Troy, HRH Princess Dina Mired, HRH Princess Ghida Talal, HE Zainab Shinkafi-Bagudu, Felicia Knaul, and others whose work influences access, equity, systems, and outcomes.
And in every issue no matter the topic patients were present. Through interviews, personal narratives, or patient-focused articles, the centre stayed the same: patient-first, always.
ONCOFFEE: The Conversations Behind The Headlines
In 2025, ONCOFFEE became one of our most human series, less formal, more direct, and built around real voices. It was the space where oncology leaders, rising experts, and guests could share perspectives beyond the usual soundbites: career journeys, lessons learned, honest opinions, and the stories that don’t always fit into a standard article.
Grants & Fellowships: Weekly Opportunities
In 2025, we also strengthened a part of oncology media that directly supports careers: opportunities. OncoDaily expanded its Grants and Fellowship coverage to help researchers, trainees, and early-career professionals find the right programs faster.
Every week, we delivered our Top 10 OncoGrants, a reliable, easy-to-follow roundup of key grants, calls, and fellowship opportunities, so the community wouldn’t miss deadlines or major funding chances.
OncoDaily Weekly: Not To Miss
Oncology doesn’t pause and neither does the news. That’s why in 2025 we kept growing OncoDaily Weekly: a simple promise to the community.
If you missed the week, don’t worry. OncoDaily Weekly brought the key updates together in one place, top stories, major data, the biggest conversations, and the moments that actually moved the field, so you could catch up fast and stay current without scrolling for hours.
Thank You for Building This With Us
To every reader, follower, contributor, partner, clinician, researcher, advocate, and supporter, thank you for being part of OncoDaily in 2025.
We’re stepping into 2026 with bigger plans and the same promise: to keep oncology visible, connected, and moving forward every single day.
Written by Nare Hovhannisyan, MD